Hochstenbach Laura M J, Determann Domino, Fijten Rianne R R, Bloemen-van Gurp Esther J, Verwey Renée
Center of Expertise for Innovative Care and Technology (EIZT), School of Nursing, Zuyd University of Applied Sciences, P.O. Box 550, 6400 AN Heerlen, the Netherlands.
Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Faculty of Health Medicine and Life Sciences, Maastricht University, P.O. Box 616, 6200 MD Maastricht, the Netherlands.
Internet Interv. 2023 Feb 1;31:100606. doi: 10.1016/j.invent.2023.100606. eCollection 2023 Mar.
Different curative treatment modalities need to be considered in case of localized prostate cancer, all comparable in terms of survival and recurrence though different in side effects. To better inform patients and support shared decision making, the development of a web-based patient decision aid including personalized risk information was proposed. This paper reports on requirements in terms of content of information, visualization of risk profiles, and use in practice.
Based on a Dutch 10-step guide about the setup of a decision aid next to a practice guideline, an iterative and co-creative design process was followed. In collaboration with various groups of experts (health professionals, usability and linguistic experts, patients and the general public), research and development activities were continuously alternated.
Content requirements focused on presenting information only about conventional treatments and main side effects; based on risk group; and including clear explanations about personalized risks. Visual requirements involved presenting general and personalized risks separately; through bar charts or icon arrays; and along with numbers or words, and legends. Organizational requirements included integration into local clinical pathways; agreement about information input and output; and focus on patients' numeracy and graph literacy skills.
The iterative and co-creative development process was challenging, though extremely valuable. The translation of requirements resulted in a decision aid about four conventional treatment options, including general or personalized risks for erection, urinary and intestinal problems that are communicated with icon arrays and numbers. Future implementation and validation studies need to inform about use and value in practice.
对于局限性前列腺癌,需要考虑不同的治疗方式,尽管它们的副作用不同,但在生存率和复发率方面具有可比性。为了更好地为患者提供信息并支持共同决策,有人提议开发一个包含个性化风险信息的基于网络的患者决策辅助工具。本文报告了在信息内容、风险概况可视化以及实际应用方面的要求。
基于荷兰一份关于在实践指南旁边设置决策辅助工具的10步指南,遵循了一个迭代和共创的设计过程。与各类专家(卫生专业人员、可用性和语言专家、患者及公众)合作,研究和开发活动不断交替进行。
内容要求集中在仅呈现关于传统治疗方法和主要副作用的信息;基于风险组;并包括对个性化风险的清晰解释。视觉要求包括分别呈现一般风险和个性化风险;通过柱状图或图标阵列;并伴有数字或文字以及图例。组织要求包括融入当地临床路径;就信息输入和输出达成一致;并关注患者的计算能力和图表理解能力。
迭代和共创的开发过程具有挑战性,但极有价值。这些要求的转化产生了一个关于四种传统治疗选择的决策辅助工具,包括通过图标阵列和数字传达的勃起、泌尿和肠道问题的一般或个性化风险。未来的实施和验证研究需要告知其在实际应用中的使用情况和价值。